{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":1,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":1,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"2cebe55bf556","filters":{"venue":"EAU-EBU Update Series"}},"results":[{"id":"W2038344188","doi":"10.1016/j.eeus.2006.05.001","title":"Novel Therapies in Advanced Prostate Cancer","year":2006,"lang":"en","type":"article","venue":"EAU-EBU Update Series","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Docetaxel; Prostate cancer; Medicine; Oncology; Internal medicine; Cancer; Angiogenesis; Prostate; Bevacizumab; Refractory (planetary science); Clinical trial; Pharmacology; Chemotherapy; Biology","authors":[{"name":"Richard D. Sowery","is_ca":true},{"name":"Alan So","is_ca":true},{"name":"Martin Gleave","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01301246764217884,"gpt":0.2983800072524225,"spread":0.2853675396102436,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009031193,0.0003397901,0.001018454,0.001159249,0.0002789983,0.0008229336,0.0004861896,0.0006851197,0.008943135],"category_scores_gemma":[0.0007275795,0.0001394506,0.0006230013,0.0008766748,0.0002570773,0.0009304712,0.000411257,0.001030597,0.00146958],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004646991,"about_ca_system_score_gemma":0.0005757945,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004472672,"about_ca_topic_score_gemma":0.002437457,"domain_scores_codex":[0.9997872,0.00006917989,0.00002238293,0.00002147121,0.00006301561,0.00003674512],"domain_scores_gemma":[0.999668,0.0001560334,0.0000514877,0.00002094171,0.00005742241,0.00004612494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006976635,0.0003849716,0.001120133,0.002033119,0.000106459,0.0003708932,0.00005208643,0.0003989629,0.002692085,0.001968301,0.03846785,0.9517074],"study_design_scores_gemma":[0.001109859,0.003789324,0.010054,0.001434082,0.0005629194,0.003581089,0.0001363778,0.0006964408,0.003980209,0.003061805,0.9715638,0.00002993304],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008540875,0.9687467,0.0007720991,0.00513797,0.002381861,0.0000615238,0.0003210584,0.00005351191,0.0139844],"genre_scores_gemma":[0.07408758,0.8978896,0.00341042,0.003501846,0.00455709,0.000185645,0.0009035343,0.00002613391,0.01543831],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008943135,"threshold_uncertainty_score":0.02991778,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}